Search For "biotech"
Covaxin production capacity to be doubled by May-June: Centre
Updated : 4 years, 11 months ago IST
New Delhi [India], April 16 (ANI): The current production capacity of indigenously developed Covaxin vaccine will be doubled by May-June 2021 and then increased nearly 6-7 fold by July-August 2021, the government announced on Friday as the country is witnessing a record surge in COVID-19 inf
Read More
Thackeray thanks PM Modi after Centre allows Mumbai's Haffkine to produce
Updated : 4 years, 11 months ago IST
Mumbai (Maharashtra) [India], April 16 (ANI): Chief Minister Uddhav Thackeray on Thursday thanked Prime Minister Narendra Modi for allowing Maharashtra-government owned Haffkine Institute to manufacture Bharat Biotech's Covaxin, on the basis of transfer of technology.
Read More
'Covaxin' doses go missing from Jaipur hospital, FIR registered
Updated : 4 years, 11 months ago IST
Jaipur (Rajasthan) [India], April 15 (ANI): 320 doses of Bharat Biotech's COVAXIN went missing from the cold storage of Hari Bux Kanwatia Government Hospital in Jaipur on Wednesday. An FIR has been registered in the Shastri Nagar police station as vaccines went missing.
Read More
Offender DNA database will be strong deterrent to repeat crimes in India
Updated : 4 years, 11 months ago IST
New Delhi [India], April 13 (ANI/BusinessWire India): As the country debates and scrutinizes the merits of instituting a national databank of crime scene DNA profiles, several experts from the fields of forensics, biotechnology, law enforcement, criminal justice, and public policy have come
Read More
New biosealant therapy might help stabilize injury caused by cartilage bre
Updated : 4 years, 11 months ago IST
Pennsylvania [US], April 11 (ANI): The findings of a recent animal-based study suggests that a new biosealant therapy may help to stabilize injuries that cause the cartilage to break down, paving the way for a future fix, or even better, begin working right away with new cells to enhance hea
Read More
RDIF, Virchow Biotech ink deal to produce Sputnik V vaccine in India
Updated : 4 years, 11 months ago IST
Moscow [Russia], March 23 (ANI): The Russian Direct Investment Fund (RDIF) and Hyderabad-based Virchow Biotech Private Limited on Monday inked an agreement to produce up to 200 million doses per year of Sputnik V vaccine (Russian made) in India.
Read More
Nepal gives emergency approval to India's Covaxin
Updated : 4 years, 12 months ago IST
Kathmandu [Nepal], March 20 (ANI): Nepal has approved India's indigenously developed COVID-19 vaccine Covaxin for emergency use.
Read More
Mauritius receives consignment of Made in India COVID-19 vaccines
Updated : 4 years, 12 months ago IST
Port Louis [Mauritius], March 19 (ANI): In a unified attempt to free the world of coronavirus, India on Friday handed over to Mauritius a commercial supply of 200,000 doses of Covaxin vaccines under the 'Vaccine Maitri' initiative.
Read More
India doing its best to provide COVID-19 vaccine, say ambassadors of Parag
Updated : 4 years, 12 months ago IST
New Delhi [India], March 17 (ANI): Ambassadors of Paraguay and Costa Rica have hailed India's initiative to supply vaccines to other countries as part of efforts to fight the COVID-19 crisis and said they were looking forward to getting India-made vaccines.
Read More
Proud to say I got vaccinated with Covaxin: Jaishankar
Updated : 5 years ago IST
New Delhi [India], March 17 (ANI): External Affairs Minister S Jaishankar on Wednesday said he was proud to have taken 'Covaxin' and recalled that questions were raised when the indigenous COVID-19 vaccine manufactured by Bharat Biotech came to the market earlier this year.
Read More
Study shows influence of graphene nanoparticles on neurons
Updated : 5 years ago IST
Washington [US], March 11 (ANI): A new study shows that nanomaterials act on excitatory synapses, which interferes with the development of anxiety-related behaviours in vertebrates.
Read More
SEC recommends authorisation to Covaxin without 'clinical trial mode'
Updated : 5 years ago IST
New Delhi [India], March 10 (ANI): The Subject expert committee (SEC) of Drugs Controller General of India (DCGI) on Wednesday recommended removing the "clinical trial mode" condition related to Bharat Biotech's Covaxin.
Read More